Published in Infect Immun on November 01, 1980
Evaluation of virulence factor testing and characteristics of pathogenicity in Yersinia enterocolitica. Infect Immun (1983) 1.76
Catabolite repression of Escherichia coli heat-stable enterotoxin activity. J Bacteriol (1981) 1.06
Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03
Enterotoxin plasmids in bovine and porcine enterotoxigenic Escherichia coli of O groups 9, 20, 64 and 101. Can J Comp Med (1985) 0.95
Thermoactivation of a periplasmic heat-stable enterotoxin of Escherichia coli. J Bacteriol (1983) 0.88
Plasmid coding for drug resistance and production of heat-labile and heat-stable toxins harbored by an Escherichia coli strain of human origin. Infect Immun (1983) 0.88
Simultaneous detection of Escherichia coli heat-stable and heat-labile enterotoxin genes with a single RNA probe. J Clin Microbiol (1989) 0.75
Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 40.37
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. J Infect Dis (1972) 24.30
Hybridization between Escherichia coli and Shigella. J Bacteriol (1957) 18.56
Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J Med Microbiol (1971) 11.97
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
The enterotoxin plasmids of Escherichia coli. J Infect Dis (1974) 9.10
Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans. Infect Immun (1972) 6.21
Role of toxigenic and invasive bacteria in acute diarrhea of childhood. N Engl J Med (1975) 4.23
The E. coli gene encoding heat stable toxin is a bacterial transposon flanked by inverted repeats of IS1. Nature (1979) 3.94
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Strand and site specificity of the relaxation event for the relaxation complex of the antibiotic resistance plasmid R6K. Biochemistry (1974) 2.81
Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet (1978) 2.65
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49
Naturally occurring plasmid carrying genes for enterotoxin production and drug resistance. Science (1977) 2.22
Plasmid-mediated properties of a heat-stable enterotoxin-producing Escherichia coli associated with infantile diarrhea. Infect Immun (1976) 1.67
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
Antimicrobial susceptibility of enterotoxigenic Escherichia coli. J Antimicrob Chemother (1978) 0.85
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia (2007) 3.95
Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med (1976) 2.94
Strand and site specificity of the relaxation event for the relaxation complex of the antibiotic resistance plasmid R6K. Biochemistry (1974) 2.81
Genetic aberrations and survival in plasma cell leukemia. Leukemia (2008) 2.69
Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother (1973) 2.52
Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries. Bull World Health Organ (1991) 2.36
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia (2003) 2.28
R factors in strains of Salmonella typhi and Shigella dysenteriae 1 isolated during epidemics in Mexico: classification by compatibility. Antimicrob Agents Chemother (1974) 2.27
Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia (2011) 2.12
Thalidomide as initial therapy for early-stage myeloma. Leukemia (2003) 2.02
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial. Leukemia (2009) 1.97
Beta-lactamase of R factors. J Bacteriol (1968) 1.89
Enterotoxigenic Escherichia coli and diarrheal disease in Mexican children. J Infect Dis (1977) 1.84
Prospective study of enteropathogens in children with diarrhea in Houston and Mexico. J Pediatr (1978) 1.82
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia (2010) 1.77
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
An epidemic-associated episome? J Infect Dis (1972) 1.72
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy. Leukemia (2007) 1.66
Clinical significance of TP53 mutation in myeloma. Leukemia (2007) 1.62
Characterization of an R-plasmid associated with ampicillin resistance in Shigella dysenteriae type 1 isolated from epidemics. Antimicrob Agents Chemother (1977) 1.57
Clinical and biological significance of RAS mutations in multiple myeloma. Leukemia (2008) 1.56
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma. Leukemia (2013) 1.54
Enteropathogens associated with pediatric diarrhea in Mexico City. J Pediatr (1977) 1.53
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. Leukemia (2005) 1.51
Properties of the relaxation complexes of supercoiled deoxyribonucleic acid and protein of the R plasmids R64, R28K, and R6K. J Bacteriol (1974) 1.50
Complete resolution of reflex sympathetic dystrophy with thalidomide treatment. Arch Intern Med (2001) 1.47
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol (2001) 1.45
Fecal leukocytes in enteric infections. Am J Clin Pathol (1977) 1.44
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project. Leukemia (2012) 1.43
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations. Leukemia (2006) 1.39
Role of beta-1,3-glucanase in postmeiotic microspore release. Dev Biol (1977) 1.38
Thalidomide for previously untreated indolent or smoldering multiple myeloma. Leukemia (2001) 1.36
Thalidomide in the treatment of relapsed multiple myeloma. Mayo Clin Proc (2000) 1.30
Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res (2000) 1.28
A long-term retrospective study of young women with essential thrombocythemia. Mayo Clin Proc (2001) 1.27
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma. Leukemia (2008) 1.24
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol (1998) 1.23
Expression of VEGF and its receptors by myeloma cells. Leukemia (2003) 1.18
Cloning, sequencing, and expression in Ficoll-generated minicells of an Escherichia coli heat-stable enterotoxin gene. Plasmid (1988) 1.18
Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature. Leukemia (2007) 1.18
Humoral immune response to the heat-labile enterotoxin of Escherichia coli in naturally acquired diarrhea and antitoxin determination by passive immune hemolysis. Infect Immun (1977) 1.15
Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol (2004) 1.15
The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance. Blood (2001) 1.12
The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am J Clin Pathol (2000) 1.10
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse. Leukemia (2012) 1.09
Resistance of Shigella dysenteriae type 1 to ampicillin and other antimicrobial agents: strains isolated during a dysentery outbreak in a hospital in Mexico City. J Infect Dis (1976) 1.08
Induction of adrenal suppression by megestrol acetate. Ann Intern Med (1996) 1.07
Estimates of genetic parameters for reproductive traits in Brahman cattle breed. J Anim Sci (2015) 1.07
Location of food consumption and travelers' diarrhea. Am J Epidemiol (1977) 1.07
Regulation of beta-1,3-glucanase activity in developing anthers of Lilium. Dev Biol (1973) 1.06
Megestrol acetate-induced adrenal suppression. J Clin Oncol (1996) 1.06
Catabolite repression of Escherichia coli heat-stable enterotoxin activity. J Bacteriol (1981) 1.06
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma. Bone Marrow Transplant (1999) 1.05
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood (2001) 1.05
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma. Cancer Genet Cytogenet (1999) 1.05
Methods for estimation of bone marrow plasma cell involvement in myeloma: predictive value for response and survival in patients undergoing autologous stem cell transplantation. Am J Hematol (2001) 1.04
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma. Leukemia (2010) 1.03
Single-dose tetracycline therapy for shigellosis in adults. JAMA (1978) 1.02
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant (2004) 1.02
Relationship of multiple forms of chromogranin. J Biol Chem (1985) 1.01
Waldenström's macroglobulinemia. Oncologist (2000) 1.01
High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy. Bone Marrow Transplant (2004) 0.99
The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol (2008) 0.97
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma. Leukemia (2010) 0.97
[Isolation of S. typhi resistent to high concentrations of chloramphenicol]. Bol Oficina Sanit Panam (1973) 0.96
Near-GeV acceleration of electrons by a nonlinear plasma wave driven by a self-guided laser pulse. Phys Rev Lett (2009) 0.95
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma. Bone Marrow Transplant (2004) 0.95
Effect of complete response on outcome following autologous stem cell transplantation for myeloma. Bone Marrow Transplant (2000) 0.95
IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma. Leukemia (2006) 0.95
Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J (2013) 0.94
Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J Infect Dis (1977) 0.94
Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial. Leukemia (2010) 0.94
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia (2004) 0.93
Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution. Leukemia (2007) 0.92
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma. Bone Marrow Transplant (1999) 0.92
Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol (1977) 0.91
[Antibiotic resistance factors found in enteropathogenic bacteria isolated in Mexico City]. Rev Latinoam Microbiol (1971) 0.89
[Advances of drug therapy. II. Drug therapy of salmonellosis]. Gac Med Mex (1969) 0.89
Thermoactivation of a periplasmic heat-stable enterotoxin of Escherichia coli. J Bacteriol (1983) 0.88
6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis. Br J Haematol (2007) 0.88
Reliable identification of reovirus-like agent in diarrheal stools. J Lab Clin Med (1977) 0.87
Expression and mutation status of candidate kinases in multiple myeloma. Leukemia (2007) 0.87
Fibrosarcoma of the trachea with severe tracheal obstruction. Thorax (1973) 0.87
Very high Mach-number electrostatic shocks in collisionless plasmas. Phys Rev Lett (2006) 0.87
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P). Ann Hematol (2015) 0.87
Audio computer-assisted survey instrument versus face-to-face interviews: optimal method for detecting high-risk behaviour in pregnant women and their sexual partners in the south of Brazil. Int J STD AIDS (2013) 0.86
SALMONELLA ISOLATED FROM HUMAN MESENTERIC LYMPH NODES. Science (1944) 0.86
Plasma cell leukemia. Curr Treat Options Oncol (2001) 0.86
Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype. Leukemia (2012) 0.86
Antimicrobial susceptibility of enterotoxigenic Escherichia coli. J Antimicrob Chemother (1978) 0.85
Autoantibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated Shigella plasmid. J Clin Invest (1990) 0.85
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma. J Clin Oncol (1999) 0.84
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia (1999) 0.84
Autologous stem cell transplantation for relapsed and primary refractory myeloma. Bone Marrow Transplant (1999) 0.83
Wegener's granulomatosis appearing initially in the trachea. Ann Otol Rhinol Laryngol (1983) 0.83
Phospholipid membranes form specific nonbilayer molecular arrangements that are antigenic. J Biol Chem (1999) 0.83
Absence of tissue factor expression by neoplastic plasma cells in multiple myeloma. Leukemia (2012) 0.82